22 July 2020 – Race Oncology Limited (ASX:RAC) is pleased to announce that Dr Daniel Tillett…
07
Jul
Proactive Investors reported on Race’s recent first half clinical programs update. Read the full story here.
Proactive Investors reported on Race’s recent first half clinical programs update. Read the full story here.
